State Street Corp Mirum Pharmaceuticals, Inc. Transaction History
State Street Corp
- $2.21 Trillion
- Q1 2024
A detailed history of State Street Corp transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, State Street Corp holds 2,822,472 shares of MIRM stock, worth $96.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,822,472
Previous 1,734,775
62.7%
Holding current value
$96.5 Million
Previous $51.2 Million
38.45%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding MIRM
# of Institutions
183Shares Held
54.3MCall Options Held
85KPut Options Held
59.7K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$222 Million8.57% of portfolio
-
Bvf Inc San Francisco, CA4.37MShares$149 Million3.29% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.3MShares$113 Million1.34% of portfolio
-
Janus Henderson Group PLC London, X02.77MShares$94.6 Million0.04% of portfolio
-
Black Rock Inc. New York, NY2.45MShares$83.8 Million0.0% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.26B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...